Login or Sign Up
Themis Medicare Ltd. Financials
15:49 Jul 18
Themis Medicare Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Themis Medicare Ltd.
Industry Pharmaceuticals
15:49 Jul 18
Quality
64/100
High Financial Strength
Valuation
37/100
Mid Valuation
Technical
31/100
Technically Bearish
Strength
4
Weakness
15
Opportunity
0
Threats
0
7.41 %
ROE %
5.07 %
ROA %
3.24
EPS
43.74
BVPS
7.35 %
Net Profit Margin
| Mar 2023 | Mar 2024 | Mar 2025 | ||
|---|---|---|---|---|
| Net Sales | 354.32 | 381.76 | 405.51 | |
| Operating Expenses + | 286.88 | 330.25 | 356.46 | |
| Raw Material | 126.16 | 138.28 | 149.98 | |
| Increase Decrease in Cost | -7.79 | -1.57 | -17.98 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 66.15 | 82.41 | 96.38 | |
| Miscellaneous Expenses | 162.6 | 218.35 | 275.42 | |
| Operating Profit | 67.44 | 51.51 | 49.05 | |
| Other Income | 11.5 | 4.76 | 4.67 | |
| Depreciation | 10.49 | 12.25 | 9.93 | |
| Interest | 9.56 | 9.38 | 10.04 | |
| Profit before tax and exceptio.. | 58.9 | 34.64 | 33.75 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | 58.9 | 34.64 | 33.75 | |
| Provision for Taxation | 15.61 | 9.92 | 9.84 | |
| Net Profit | 43.28 | 24.72 | 23.91 | |
| NET Profit after MI | 56.9 | 43.52 | 29.83 | |
| EPS | 61.83 | 4.73 | 3.24 | |
| Operating Profit Margin (%) | 19.03 | 13.49 | 12.1 | |
| Net Profit Margin (%) | 16.06 | 11.4 | 7.36 |
Themis Medicare Ltd. Shareholding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|---|---|
| Promoter | 67.20 | 67.20 | 67.20 | 67.20 | 67.20 |
| FII | 0.10 | 0.10 | 0.10 | 0.10 | 0.00 |
| MF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | -0.10 | 0.00 | -0.10 | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
